Argitalpenak (402) Pablo Miguel Barreiro Garcia argitalpenak Ikerketa datu erreferentziatuak ikusi.

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. Coinfection with Viral Hepatitis in HIV patients in 2023

    AIDS reviews, Vol. 25, Núm. 1, pp. 65-66

  3. Cross-Sectional Analysis of Risk Factors for Outbreak of COVID-19 in Nursing Homes for Older Adults in the Community of Madrid

    Gerontology, Vol. 69, Núm. 2, pp. 163-171

  4. Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2

    Viruses, Vol. 15, Núm. 7

  5. Genetic signature detected in T cell receptors from patients with severe COVID-19

    iScience, Vol. 26, Núm. 10

  6. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain

    Alimentary Pharmacology and Therapeutics, Vol. 57, Núm. 5, pp. 540-548

  7. Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain

    Journal of Clinical Virology, Vol. 167

  8. Rebound in sexually transmitted infections after the COVID-19 pandemic

    AIDS reviews, Vol. 26, Núm. 3, pp. 127-135

  9. Risk of severe COVID in solid organ transplant recipients

    Revista Espanola de Quimioterapia, Vol. 36, pp. 15-17

  10. Safety considerations in the management of hepatitis C and HIV co-infection

    Expert Opinion on Drug Safety, Vol. 22, Núm. 5, pp. 363-372

  11. Temporal Series Analysis of Population Cycle Threshold Counts as a Predictor of Surge in Cases and Hospitalizations during the SARS-CoV-2 Pandemic

    Viruses, Vol. 15, Núm. 2

  12. The new profile of psychiatric disorders in patients with HIV infection

    AIDS Reviews, Vol. 25, Núm. 1, pp. 41-53

  13. Treatment of hepatitis delta and HIV infection

    Liver International, Vol. 43, Núm. S1, pp. 108-115

  14. Triple Threat: HDV, HBV, HIV Coinfection

    Clinics in Liver Disease, Vol. 27, Núm. 4, pp. 955-972

  15. Viral hepatitis in persons living with HIV in the post-COVID era

    AIDS reviews, Vol. 25, Núm. 1, pp. 1-13